NCT06570473: Feasibility Trial for a Right Ventricular Failure Platform Trial
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 15 Jul 2025
- Primary completion
- 31 Mar 2027
- Arms
- Empagliflozin
- Results
- None posted
- 26 Aug 2024: Trial registered
- 15 Jul 2025: Trial started